Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Fixed Capital/Sales

    Back to All Ratios
AD     Remove this Ad

LASA SUPERGENERICS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 2.201.781.681.101.29

What is the latest Fixed Capital/Sales ratio of LASA SUPERGENERICS ?

The latest Fixed Capital/Sales ratio of LASA SUPERGENERICS is 2.20 based on Mar2024 Standalone results.
Year Fixed Capital/Sales
Mar20242.20
Mar20231.78
Mar20221.68
Mar20211.10
Mar20201.29

How is Fixed Capital/Sales of LASA SUPERGENERICS Trending?

Years Fixed Capital/Sales % Change
Mar2024 2.2
23.60
Mar2023 1.78
5.95
Mar2022 1.68
52.73
Mar2021 1.1
-14.73
Mar2020 1.29 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Fixed Capital/Sales ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹40.5 Cr 0.5% -12.3% -65.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

0.5%

-12.3%

-65.4%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses